Literature DB >> 14573776

Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions.

Mario Muredda1, Ken-Ichi Nunoya, Ruth A Burtch-Wright, Ebba U Kurz, Susan P C Cole, Roger G Deeley.   

Abstract

The ATP-binding cassette transporter multidrug resistance protein 1 (MRP1) confers resistance to a number of clinically important chemotherapeutic agents. The proximal promoter region of MRP1 is GC-rich and contains binding sites for members of the Sp1 family of trans-acting factors that seem to be important for basal expression. As an approach to searching for other elements that may contribute to expression, we have sequenced and functionally compared the promoters of the murine and rat mrp1 genes with that of the human gene. All three promoters are GC-rich, TATA-less, and CAAT-less. Conservation of sequence between rodent and human promoters is limited to a proximal region of 100 nucleotides containing binding sites for members of the Sp1 family and a putative activator protein-1 element. The 5'-untranslated region (UTR) of human MRP1 contains an insertion of approximately 160 nucleotides comprising a GCC-triplet repeat and a GC-rich tandem repeat that is absent from the rodent sequences. Transient transfection analyses demonstrated that the conserved GC-boxes of all three genes are the major determinants of basal activity. Based on electrophoretic mobility shift assays, each GC-box can be bound by Sp1 or Sp3. Unlike the rodent genes, the human MRP1 5'UTR also binds Sp1 but not Sp3, and the human promoter retains substantial activity even in the absence of the conserved GC-boxes. Finally, we show that the tumor suppressor protein p53 can repress the human and rodent promoters by a mechanism that is independent of the Sp1 elements.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573776     DOI: 10.1124/mol.64.5.1259

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

Review 1.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

2.  Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation.

Authors:  Laurence Bousquet; Alain Pruvost; Anne-Cécile Guyot; Robert Farinotti; Aloïse Mabondzo
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

3.  Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.

Authors:  Christopher M Mahaffey; Hongqiao Zhang; Alessandra Rinna; William Holland; Philip C Mack; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2009-04-05       Impact factor: 7.376

4.  Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner.

Authors:  Mohammed-Amine El Azreq; Dalila Naci; Fawzi Aoudjit
Journal:  Mol Biol Cell       Date:  2012-07-11       Impact factor: 4.138

5.  Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region.

Authors:  Zihua Wang; Pui-Hoon Sew; Helen Ambrose; Stephen Ryan; Samuel S Chong; Edmund J D Lee; Caroline G L Lee
Journal:  BMC Genomics       Date:  2006-05-10       Impact factor: 3.969

6.  Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer.

Authors:  Yingqian Lv; Shan Zhao; Jinzhu Han; Likang Zheng; Zixin Yang; Li Zhao
Journal:  Onco Targets Ther       Date:  2015-07-29       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.